229 related articles for article (PubMed ID: 2320112)
1. Expression of an erythroid transcription factor in megakaryocytic and mast cell lineages.
Martin DI; Zon LI; Mutter G; Orkin SH
Nature; 1990 Mar; 344(6265):444-7. PubMed ID: 2320112
[TBL] [Abstract][Full Text] [Related]
2. Megakaryocytic and erythrocytic lineages share specific transcription factors.
Romeo PH; Prandini MH; Joulin V; Mignotte V; Prenant M; Vainchenker W; Marguerie G; Uzan G
Nature; 1990 Mar; 344(6265):447-9. PubMed ID: 2320113
[TBL] [Abstract][Full Text] [Related]
3. Transcription of the SCL gene in erythroid and CD34 positive primitive myeloid cells is controlled by a complex network of lineage-restricted chromatin-dependent and chromatin-independent regulatory elements.
Göttgens B; McLaughlin F; Bockamp EO; Fordham JL; Begley CG; Kosmopoulos K; Elefanty AG; Green AR
Oncogene; 1997 Nov; 15(20):2419-28. PubMed ID: 9395238
[TBL] [Abstract][Full Text] [Related]
4. Effects of chebulinic acid on differentiation of human leukemia K562 cells.
Yi ZC; Wang Z; Li HX; Liu MJ; Wu RC; Wang XH
Acta Pharmacol Sin; 2004 Feb; 25(2):231-8. PubMed ID: 14769215
[TBL] [Abstract][Full Text] [Related]
5. Expression of megakaryocytic and erythroid properties in human leukemic cells.
Tani T; Ylänne J; Virtanen I
Exp Hematol; 1996 Feb; 24(2):158-68. PubMed ID: 8641337
[TBL] [Abstract][Full Text] [Related]
6. SCL expression at critical points in human hematopoietic lineage commitment.
Zhang Y; Payne KJ; Zhu Y; Price MA; Parrish YK; Zielinska E; Barsky LW; Crooks GM
Stem Cells; 2005; 23(6):852-60. PubMed ID: 15917481
[TBL] [Abstract][Full Text] [Related]
7. Growth factor receptor expression during in vitro differentiation of partially purified populations containing murine stem cells.
Ashihara E; Vannucchi AM; Migliaccio G; Migliaccio AR
J Cell Physiol; 1997 Jun; 171(3):343-56. PubMed ID: 9180904
[TBL] [Abstract][Full Text] [Related]
8. Cloning of cDNA for the major DNA-binding protein of the erythroid lineage through expression in mammalian cells.
Tsai SF; Martin DI; Zon LI; D'Andrea AD; Wong GG; Orkin SH
Nature; 1989 Jun; 339(6224):446-51. PubMed ID: 2725678
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of the LYL, SCL and E2A helix-loop-helix genes within the hemopoietic system.
Visvader J; Begley CG; Adams JM
Oncogene; 1991 Feb; 6(2):187-94. PubMed ID: 2000219
[TBL] [Abstract][Full Text] [Related]
10. Mouse microcytic anaemia caused by a defect in the gene encoding the globin enhancer-binding protein NF-E2.
Peters LL; Andrews NC; Eicher EM; Davidson MB; Orkin SH; Lux SE
Nature; 1993 Apr; 362(6422):768-70. PubMed ID: 8469289
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-4 downregulates nuclear factor-erythroid 2 (NF-E2) expression in primary megakaryocytes and in megakaryoblastic cell lines.
Catani L; Amabile M; Luatti S; Valdrè L; Vianelli N; Martinelli G; Tura S
Stem Cells; 2001; 19(4):339-47. PubMed ID: 11463954
[TBL] [Abstract][Full Text] [Related]
12. Expression and regulation of NFAT (nuclear factors of activated T cells) in human CD34+ cells: down-regulation upon myeloid differentiation.
Kiani A; Habermann I; Haase M; Feldmann S; Boxberger S; Sanchez-Fernandez MA; Thiede C; Bornhäuser M; Ehninger G
J Leukoc Biol; 2004 Nov; 76(5):1057-65. PubMed ID: 15292278
[TBL] [Abstract][Full Text] [Related]
13. Erythroid transcription factor NF-E2 is a haematopoietic-specific basic-leucine zipper protein.
Andrews NC; Erdjument-Bromage H; Davidson MB; Tempst P; Orkin SH
Nature; 1993 Apr; 362(6422):722-8. PubMed ID: 8469283
[TBL] [Abstract][Full Text] [Related]
14. A self-renewing, bipotential erythroid/mast cell progenitor in continuous cultures of normal murine bone marrow.
Wendling F; Shreeve M; McLeod D; Axelrad A
J Cell Physiol; 1985 Oct; 125(1):10-8. PubMed ID: 2931443
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
Suhasini M; Boss GR; Pascual FE; Pilz RB
Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
[TBL] [Abstract][Full Text] [Related]
16. Dependence for the proliferative response to erythropoietin on an established erythroid differentiation program in a human hematopoietic cell line, UT-7.
Nicolis S; Ottolenghi S; Papayannopoulou T; Baiocchi M; Migliaccio G; Adamson J; Migliaccio AR
Exp Hematol; 1993 May; 21(5):665-70. PubMed ID: 8513868
[TBL] [Abstract][Full Text] [Related]
17. Induced myeloid differentiation of K562 cells with downregulation of erythroid and megakaryocytic transcription factors: a novel experimental model for hemopoietic lineage restriction.
Green AR; Rockman S; DeLuca E; Begley CG
Exp Hematol; 1993 Apr; 21(4):525-31. PubMed ID: 8462662
[TBL] [Abstract][Full Text] [Related]
18. Stem cell factor and interleukin-3 induce stepwise generation of erythroid precursor cells from a basic fibroblast growth factor-dependent hematopoietic stem cell line, A-6.
Anzai H; Ikawa Y; Atsumi T
Biochem Biophys Res Commun; 2001 Apr; 282(4):940-6. PubMed ID: 11352642
[TBL] [Abstract][Full Text] [Related]
19. Induction of erythroid gene expression by microcell fusion.
Kanamori H; Siegel JN
Exp Cell Res; 1997 Apr; 232(1):90-6. PubMed ID: 9141625
[TBL] [Abstract][Full Text] [Related]
20. A newly established megakaryoblastic/erythroid cell line that differentiates to red cells in the presence of erythropoietin and produces platelet-like particles.
Tsuyuoka R; Takahashi T; Suzuki A; Sasaki Y; Nakamura K; Fukumoto M; Ohmori K; Ohno Y; Nakao K
Stem Cells; 1995 Jan; 13(1):54-64. PubMed ID: 7719248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
